SAN ANTONIO — March 23, 2026 — Southwest Research Institute (SwRI) celebrated the grand opening of its new Clinical Supply Facility (CSF). The 21,000-square-foot laboratory adds dedicated suites and HEPA filtered cleanrooms to support pharmaceutical development and bioengineering research, particularly in advanced clinical supplies. The facility expands SwRI’s capability to conduct “Fill Finish” for capsules, sachets, tablets and other advanced formulations for all routes of administration. The facility will facilitate the production of active pharmaceutical ingredients, formulated products, and biologics or cell-based materials such as in vitro generated stem cells and vaccine components.

CGI-Clinics hosts a free webinar on 9 April to present the Cancer Genome Interpreter (CGI) platform

A review paper by scientists at Peking University Third Hospital investigates underlying determinants of low translational success of central nervous system drugs and therapeutic devices, reviews the historical and technical bottlenecks that lead to the neglect of ECS research, and emphasizes its transformative potential in reshaping therapeutic strategies.

The review paper, published on Mar 4, 2026 in the journal Cyborg and Bionic Systems.

New blood tests for diagnosing Alzheimer’s disease are making early diagnosis increasingly feasible. However, the fact that the markers being measured change long before any symptoms develop represents a challenge. Research led by Lund University in Sweden shows that a previously unused blood marker, when combined with those markers already in use, can significantly reduce the risk of misleading diagnoses.

School at the State University of Campinas (Brazil) features comprehensive content, including epidemiological aspects, genetic nutrition, epigenetics, molecular and cellular aspects, and advances in preventive and therapeutic interventions. Register by Ma